Trials / Terminated
TerminatedNCT00038701
Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas
Phase II Study of Gemcitabine-Based Chemoradiation and TNP-470 for Patients With Locally Advanced, Nonmetastatic Adenocarcinoma of the Pancreas
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal is to assess survival and patterns of failure in patients treated with Gemzar-based chemoradiation and TNP-470 for locally advanced adenocarcinoma of the pancreas.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TNP-470 |
Timeline
- Start date
- 1999-08-01
- Primary completion
- 2004-05-11
- Completion
- 2004-05-11
- First posted
- 2002-06-05
- Last updated
- 2018-11-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00038701. Inclusion in this directory is not an endorsement.